Earnings History Data for Cumberland Pharmaceuticals Inc. (CPIX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | CPIX | Cumberland Pharmaceuticals Inc. | 16.63 | -0.03 | 0.00 | 0.02 | Cumberland Pharmaceuticals Non-GAAP EPS of -$0.02, revenue of $9.1M [11/8/2024 6:20 AM] |
1.20 | 0.0 (0.00%) |
1.15 | -0.05 (-4.17%) |
1.07 - 2.36 | 88,546 | 120,000 | 8,258 | ||
| 06-08-2024 | AH | CPIX | Cumberland Pharmaceuticals Inc. | 20.29 | N/A | 0.00 | 0.15 | Cumberland Pharmaceuticals Non-GAAP EPS of $0.01, revenue of $9.9M [8/6/2024 4:49 PM] |
1.48 | -0.02 (-1.33%) |
1.55 | 0.05 (3.33%) |
1.38 - 2.36 | 4,217 | 10,000 | 1,000 | ||
| 07-05-2024 | AH | CPIX | Cumberland Pharmaceuticals Inc. | 21.53 | -0.06 | 0.00 | 0.10 | Cumberland Pharmaceuticals Non-GAAP EPS of -$0.05, revenue of $8.5M [5/7/2024 4:39 PM] |
1.65 | 0.07 (4.43%) |
0.0 | 0.0 (0.00%) |
1.42 - 2.36 | 7,760 | 10,000 | 0 | ||
| 07-11-2023 | AH | CPIX | Cumberland Pharmaceuticals Inc. | 29.03 | 0.02 | 0.00 | 0.09 | Cumberland Pharmaceuticals Non-GAAP EPS of $0.02, revenue of $10.1M [11/7/2023 4:43 PM] |
1.89 | -0.16 (-7.80%) |
2.05 | 0.0 (0.00%) |
1.43 - 2.91 | 32,202 | 20,000 | 172 | ||
| 08-08-2023 | AH | CPIX | Cumberland Pharmaceuticals Inc. | 21.67 | 0.15 | 0.00 | -0.01 | Cumberland Pharmaceuticals GAAP EPS of $0.06, revenue of $10.9M [8/8/2023 5:12 PM] |
1.66 | 0.23 (16.09%) |
1.55 | 0.12 (8.39%) |
1.43 - 2.91 | 83,325 | 10,000 | 5,285 | ||
| 09-05-2023 | AH | 4:05 PM ET (May 9) |
CPIX | Cumberland Pharmaceuticals Inc. | 24.90 | 0.10 | 0.00 | 0.02 | Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $9.2M [5/9/2023 4:54 PM] |
1.77 | 0.09 (5.36%) |
0.0 | 0.0 (0.00%) |
1.60 - 2.91 | 4,794 | 10,000 | 0 | |
| 07-03-2023 | AH | 4:05 PM ET (Mar 7) |
CPIX | Cumberland Pharmaceuticals Inc. | 34.14 | -0.06 | 0.00 | -0.14 | Cumberland Pharmaceuticals GAAP EPS of -$0.17, revenue of $9.12M [3/7/2023 4:25 PM] |
2.25 | -0.06 (-2.60%) |
0.0 | 0.0 (0.00%) |
1.89 - 3.17 | 5,161 | 10,000 | 0 | |
| 08-11-2022 | AH | 4:05 PM ET (Nov 8) |
CPIX | Cumberland Pharmaceuticals Inc. | 35.63 | 0.09 | 0.00 | -0.03 | Cumberland Pharmaceuticals Non-GAAP EPS of $0.10, revenue of $11.41M [11/8/2022 4:51 PM] |
2.29 | -0.01 (-0.43%) |
2.43 | 0.13 (5.65%) |
1.89 - 7.51 | 17,232 | 10,000 | 702 | |
| 09-08-2022 | AH | 4:05 PM ET (Aug 9) |
CPIX | Cumberland Pharmaceuticals Inc. | 35.73 | -0.01 | 0.00 | -0.01 | Cumberland Pharmaceuticals Non-GAAP EPS of -$0.01, revenue of $10.3M [8/9/2022 4:38 PM] |
2.41 | 0.31 (14.72%) |
0.0 | 0.0 (0.00%) |
1.89 - 7.51 | 22,049 | 10,000 | 0 | |
| 10-05-2022 | AH | 4:05 PM ET (May 10) |
CPIX | Cumberland Pharmaceuticals Inc. | 35.77 | 0.02 | 0.00 | 0.06 | Cumberland Pharmaceuticals Non-GAAP EPS of $0.03, revenue of $11.2M [5/10/2022 5:02 PM] |
2.22 | -0.36 (-13.95%) |
2.44 | -0.18 (-6.87%) |
2.17 - 7.51 | 55,821 | 30,000 | 500 | |
|
||||||||||||||||||
| 08-03-2022 | AH | 4:05 PM ET (Mar 8) |
CPIX | Cumberland Pharmaceuticals Inc. | 46.62 | -0.14 | 0.00 | -0.01 | Cumberland Pharmaceuticals GAAP EPS of -$0.29 misses by $0.26, revenue of $8.3M misses by $32.67M [3/8/2022 4:43 PM] |
2.51 | -0.22 (-8.06%) |
0.0 | 0.0 (0.00%) |
2.20 - 7.51 | 79,626 | 30,000 | 0 | |
| 09-11-2021 | AH | 4:05 PM ET (Nov 9) |
CPIX | Cumberland Pharmaceuticals Inc. | 40.17 | -0.03 | 0.00 | 0.00 | Cumberland Pharmaceuticals reports Q3 results [11/9/2021 4:20 PM] |
2.88 | -0.32 (-10.04%) |
2.93 | -0.27 (-8.48%) |
2.57 - 3.94 | 281,864 | 80,000 | 287 | |
| 10-08-2021 | AH | 4:05 PM ET (Aug 10) |
CPIX | Cumberland Pharmaceuticals Inc. | 43.49 | -0.01 | -0.09 | 0.07 | Cumberland Pharmaceuticals EPS beats by $0.18, beats on revenue [8/10/2021 4:44 PM] |
2.90 | -0.02 (-0.59%) |
2.98 | 0.06 (2.05%) |
2.58 - 3.94 | 19,317 | 20,000 | 622 | |
| 11-05-2021 | AH | 4:05 PM ET (May 11) |
CPIX | Cumberland Pharmaceuticals Inc. | 39.69 | 0.06 | -0.09 | -0.01 | Cumberland Pharmaceuticals EPS beats by $0.14, beats on revenue [5/11/2021 4:22 PM] |
2.69 | 0.09 (3.53%) |
2.70 | 0.10 (3.91%) |
2.58 - 4.01 | 60,361 | 20,000 | 1,173 | |
| 09-03-2021 | AH | 4:05 PM ET (Mar 9) |
CPIX | Cumberland Pharmaceuticals Inc. | 46.78 | -0.01 | -0.03 | 0.07 | Cumberland Pharmaceuticals EPS beats by $0.02, beats on revenue [3/9/2021 4:12 PM] |
3.20 | -0.08 (-2.44%) |
3.29 | 0.01 (0.30%) |
2.77 - 4.30 | 89,259 | 54,511 | 1,700 | |
|
||||||||||||||||||
| 10-11-2020 | AH | 4:05 PM ET (Nov 10) |
CPIX | Cumberland Pharmaceuticals Inc. | 44.05 | N/A | -0.09 | -0.02 | Cumberland Pharmaceuticals EPS beats by $0.10, beats on revenue [11/10/2020 4:15 PM] |
3.05 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
2.77 - 5.80 | 173,175 | 12,679 | 0 | |
|
|
||||||||||||||||||
| 11-08-2020 | AH | 4:05 PM ET (Aug 11) |
CPIX | Cumberland Pharmaceuticals Inc. | 51.24 | 0.07 | 0.01 | 0.07 | Cumberland Pharmaceuticals EPS beats by $0.05, beats on revenue [8/11/2020 4:25 PM] |
3.43 | 0.05 (1.48%) |
3.65 | 0.27 (7.99%) |
3.10 - 6.10 | 39,802 | 24,403 | 993 | |
|
|
||||||||||||||||||
| 20-05-2020 | AH | 4:05 PM ET (May 20) |
CPIX | Cumberland Pharmaceuticals Inc. | 55.87 | -0.01 | 0.00 | 0.09 | Cumberland Pharmaceuticals EPS misses by $0.01, misses on revenue [5/20/2020 4:12 PM] |
3.75 | 0.0 (0.13%) |
0.0 | 0.0 (0.00%) |
3.32 - 6.99 | 49,552 | 21,717 | 0 | |
|
|
||||||||||||||||||